Stockscreener 앱 받기
126.36
2.83%
3.48
전일 마감가:
$122.88
열려 있는:
$124.16
하루 거래량:
829.58K
Relative Volume:
0.90
시가총액:
$3.63B
수익:
$267.23M
순이익/손실:
$-83.50M
주가수익비율:
-40.63
EPS:
-3.11
순현금흐름:
$-59.99M
1주 성능:
+20.19%
1개월 성능:
+54.68%
6개월 성능:
+65.50%
1년 성능:
+284.19%
1일 변동 폭
$121.00
$127.36
1주일 범위
$104.43
$127.36
52주 변동 폭
$28.86
$127.36
Genedx Holdings Corp Stock (WGS) Company Profile
명칭
Genedx Holdings Corp
전화
888-729-1206
주소
333 LUDLOW STREET, STAMFORD
WGS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
126.36 | 3.53B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
489.01 | 183.16B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
210.93 | 150.53B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
650.84 | 52.32B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
119.20 | 33.77B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.09 | 32.20B | 15.50B | 1.33B | 2.16B | 7.34 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Piper Sandler | Overweight |
| 2025-05-15 | 개시 | Guggenheim | Buy |
| 2025-05-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-10 | 개시 | Craig Hallum | Buy |
| 2024-06-03 | 재개 | Jefferies | Hold |
모두보기
Genedx Holdings Corp 주식(WGS)의 최신 뉴스
Will GeneDx (WGS) Navigate Management Credibility Challenges After Securities Investigation News? - simplywall.st
Can GeneDx Holdings Corp. Equity Warrant outperform in the next rallyShort Setup & Precise Buy Zone Identification - mustnews.co.kr
Watch for Trend Continuation in GeneDx Holdings Corp. Next Week2025 Earnings Impact & Real-Time Volume Triggers - newsyoung.net
Can GeneDx Holdings Corp. Rally Enough to Break Even2025 Investor Takeaways & Smart Allocation Stock Tips - sundaytimes.kr
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action InvestigationWGS - Eastern Progress
WGS Investor News: If You Have Suffered Losses in GeneDx - GlobeNewswire
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are - Bluefield Daily Telegraph
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Genedx Holdings Corp. shares fall 2.20% intraday after Rosen Law Firm investigates potential securities claims. - AInvest
GeneDx Holdings Corp. Stock Lags Behind Sector BenchmarksJuly 2025 Setups & Daily Profit Maximizing Trade Tips - sundaytimes.kr
GeneDx Holdings Corp. Securities Class Action Investigation - AInvest
GeneDx Holdings stock hits 52-week high at 118.47 USD By Investing.com - Investing.com South Africa
GeneDx Holdings stock hits 52-week high at 118.47 USD - Investing.com
GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action InvestigationWGS - ACCESS Newswire
GeneDx at Canaccord Conference: Expanding Genomic Horizons By Investing.com - Investing.com Nigeria
GeneDx at Canaccord Conference: Expanding Genomic Horizons - Investing.com
Trendlines Suggest GeneDx Holdings Corp. May Bottom Out SoonSwing Trading Plan With Smart Signals in Review - metal.it
How Investors May Respond To GeneDx Holdings (WGS) Raising 2024 Revenue Guidance After Swing to Profit - simplywall.st
GeneDx Holdings Corp. (WGS) Sees Solid Earnings Growth Amid Rising Estimates - AInvest
Will GENEDX HOLDINGS (WGS) Gain on Rising Earnings Estimates? - Yahoo Finance
Genedx Holdings Corp. shares rise 1.90% after-hours as Rosen Law Firm investigates potential securities claims. - AInvest
Should You Buy GeneDx Holdings Corp. (WGS) After Golden Cross? - Zacks Investment Research
Industry Analysts Just Upgraded Their GeneDx Holdings Corp. (NASDAQ:WGS) Revenue Forecasts By 11% - 富途牛牛
GeneDx Holdings' (NASDAQ:WGS) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
William Blair Investment Management, LLC's Strategic Acquisition in GeneDx Holdings Corp - GuruFocus
GeneDx investigated for misleading statements and practices. - AInvest
Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS) - GlobeNewswire
GeneDx Leadership to Present at 3 Premier Healthcare Conferences: Morgan Stanley, Wells Fargo, Canaccord - Stock Titan
GeneDx to Participate in Upcoming Investor Conferences - Business Wire
Piper Sandler reiterates Overweight rating on GeneDx stock, citing multiyear growth potential - Investing.com Canada
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - ADVFN Brasil
Genedx Holdings Corp. shares rise 1.59% intraday after Rosen Law Firm investigates potential securities claims. - AInvest
How does GeneDx Holdings Corp. generate profit in a changing economyCapitalize on market momentum for big wins - Jammu Links News
What catalysts could drive GeneDx Holdings Corp. stock higher in 2025Maximize gains with expert analysis - Jammu Links News
Published on: 2025-08-04 06:03:13 - Jammu Links News
Is GeneDx Holdings Corp. stock overvalued or undervaluedHigh-margin investment plays - Jammu Links News
Published on: 2025-08-04 04:10:50 - Jammu Links News
What are analysts’ price targets for GeneDx Holdings Corp. Equity Warrant in the next 12 monthsTremendous gains - Jammu Links News
How many analysts rate GeneDx Holdings Corp. Equity Warrant as a “Buy”Discover high-growth stocks for your portfolio - Jammu Links News
Should I hold or sell GeneDx Holdings Corp. Equity Warrant stock in 2025Achieve rapid capital gains with smart investing - Jammu Links News
How volatile is GeneDx Holdings Corp. stock compared to the marketInvest with confidence backed by data - Jammu Links News
Is GeneDx Holdings Corp. Equity Warrant stock overvalued or undervaluedBuild a diversified portfolio for risk mitigation - Jammu Links News
How strong is GeneDx Holdings Corp. company’s balance sheetGet timely market insights for better trades - Jammu Links News
What institutional investors are buying GeneDx Holdings Corp. stockFree Daily Trading Room Entry - Jammu Links News
How strong is GeneDx Holdings Corp. Equity Warrant company’s balance sheetBuild your wealth with consistent stock growth - Jammu Links News
When is GeneDx Holdings Corp. Equity Warrant stock expected to show significant growthAchieve rapid returns with smart investment plans - Jammu Links News
What analysts say about GeneDx Holdings Corp. Equity Warrant stockSignificant capital appreciation - Jammu Links News
Is it the right time to buy GeneDx Holdings Corp. Equity Warrant stockUnlock daily market insights for better trades - Jammu Links News
Published on: 2025-08-03 12:13:18 - Jammu Links News
Genedx Holdings Corp (WGS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Genedx Holdings Corp 주식 (WGS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jul 29 '25 |
Sale |
105.31 |
388 |
40,860 |
3,757 |
| Stueland Katherine | Chief Executive Officer |
Jul 29 '25 |
Option Exercise |
0.00 |
3,874 |
0 |
5,594 |
| Stueland Katherine | Chief Executive Officer |
Jul 29 '25 |
Sale |
105.31 |
2,154 |
226,838 |
3,440 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jul 09 '25 |
Option Exercise |
32.67 |
1,245 |
40,674 |
8,670 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jul 09 '25 |
Sale |
93.00 |
5,278 |
490,854 |
3,392 |
| Stueland Katherine | Chief Executive Officer |
Jul 09 '25 |
Sale |
93.00 |
3,220 |
299,460 |
1,720 |
| Stueland Katherine | Chief Executive Officer |
Jul 01 '25 |
Sale |
90.94 |
9,657 |
878,181 |
4,940 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jul 01 '25 |
Sale |
91.12 |
1,344 |
122,471 |
7,425 |
0.67%
0.75%
자본화:
|
볼륨(24시간):